OpenAlex
PricingAboutJobs
Log inGet started
Work

Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials

HTML

Year: 2018
Type: article
Study design: Clinical Trial
Source: The Lancet Respiratory Medicine
DOI: 10.1016/s2213-2600(18)30184-x
Authors: Reynold A Panettieri, Ulf Sjöbring, AnnaMaria Péterffy, Peter Wessman, Karin Bowen, Edward Piper, Gene Colice, Christopher E Brightling
Institutions: Rutgers, The State University of New Jersey, University of Pennsylvania, AstraZeneca (Sweden), AstraZeneca (United States), AstraZeneca (United Kingdom), University of Leicester
Language: English

Topic: Asthma and respiratory diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: tralokinumab, severe uncontrolled asthma, IL-13, anti-IL-13 monoclonal antibody, treatment frequency, subcutaneous administration, oral corticosteroids, drug safety, biomarker discovery, treatment discontinuation, asthma exacerbation prevention, treatment-emergent adverse events
SDG: Good health and well-being

Open Access status: green

Funders: AstraZeneca, National Institute for Health and Care Research, National Institutes of Health, NIHR Leicester Biomedical Research Centre
OpenAlex ID: W2803404900
FWCI: 21.91
Cites: 44
Cited by: 253
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms